These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 7304441)
1. Effects of isosorbide dinitrate and hydralazine on regional metabolic responses to arm exercise in patients with heart failure. Wilson JR; Untereker W; Hirshfeld J Am J Cardiol; 1981 Nov; 48(5):934-8. PubMed ID: 7304441 [TBL] [Abstract][Full Text] [Related]
2. Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise. Wilson JR; Ferraro N Am J Med; 1981 Oct; 71(4):627-33. PubMed ID: 7282752 [TBL] [Abstract][Full Text] [Related]
3. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035 [TBL] [Abstract][Full Text] [Related]
4. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure. Massie BM; Kramer B; Shen E; Haughom F Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252 [TBL] [Abstract][Full Text] [Related]
5. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group. Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244 [TBL] [Abstract][Full Text] [Related]
6. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. Franciosa JA; Cohn JN Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762 [TBL] [Abstract][Full Text] [Related]
7. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315 [TBL] [Abstract][Full Text] [Related]
8. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination. Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384 [TBL] [Abstract][Full Text] [Related]
9. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238 [TBL] [Abstract][Full Text] [Related]
10. Effect of isosorbide dinitrate on submaximal exercise capacity of patients with chronic left ventricular failure. Wilson JR; Ferraro N Chest; 1982 Dec; 82(6):701-4. PubMed ID: 7140397 [TBL] [Abstract][Full Text] [Related]
11. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN; N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851 [TBL] [Abstract][Full Text] [Related]
12. Improvement in exercise haemodynamics by isosorbide dinitrate in patients with severe congestive cardiac failure secondary to ischaemic heart disease. Stephens J; Camm J; Spurrell R Br Heart J; 1978 Aug; 40(8):832-7. PubMed ID: 687484 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426 [TBL] [Abstract][Full Text] [Related]
14. Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey. Brewster LM ESC Heart Fail; 2019 Jun; 6(3):487-498. PubMed ID: 30892835 [TBL] [Abstract][Full Text] [Related]
15. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. Fletcher RD; Cintron GB; Johnson G; Orndorff J; Carson P; Cohn JN Circulation; 1993 Jun; 87(6 Suppl):VI49-55. PubMed ID: 8500239 [TBL] [Abstract][Full Text] [Related]
16. Effects of isosorbide dinitrate on the response to atrial pacing in coronary heart disease. Steele RJ; Burggraf GW; Parker JO Am J Cardiol; 1975 Aug; 36(2):206-10. PubMed ID: 1155342 [TBL] [Abstract][Full Text] [Related]
17. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate. Adigun AQ; Ajayi OE; Sofowora GG; Ajayi AA Int J Cardiol; 1998 Nov; 67(1):81-6. PubMed ID: 9880204 [TBL] [Abstract][Full Text] [Related]
18. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Leier CV; Huss P; Magorien RD; Unverferth DV Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742 [TBL] [Abstract][Full Text] [Related]
19. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction. Mantle JA; Russell RO; Moraski RE; Rackley CE Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)]. Lanas F; Salvatici R; Opazo JA; Saavedra J; Iturriaga J Rev Med Chil; 1979 Oct; 107(10):926-30. PubMed ID: 550229 [No Abstract] [Full Text] [Related] [Next] [New Search]